publication date: Dec. 19, 2010
In this issue:
Congress signals willingness to break with administration on NIH funding.
Von Eschenbach says he will step down as NCI director; no acting director has been named.
ODAC finds increase in progression-free survival unconvincing to approve sNDA for Gemzar in advanced ovarian cancer.
Download (PDF 839KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.